Study of disease progression and relevant risk factors in diabetic foot patients using a multistate continuous-time Markov chain model

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Begun, Alexander ^a   Morbach, Stephan ^a,b   Rümenapf, Gerhard ^c   Icks, Andrea ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Marienkrankenhaus ^*  (Germany)

^c Diakonissen Stiftungs Krankenhaus Speyer   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMPUTATION; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL EFFECTIVENESS; COMORBIDITY; DEATH; DIABETIC FOOT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GERMANY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR AMPUTATION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MINOR AMPUTATION; MODEL; MORTALITY; MULTISTATE CONTINUOUS TIME MARKOV CHAIN MODEL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK FACTOR; SEX DIFFERENCE; SURVIVAL; COMPLICATION; MARKOV CHAIN; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; RECURRENT DISEASE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMPUTATION; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DISEASE PROGRESSION; FEMALE; GERMANY; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; RECURRENCE; RISK FACTORS; SEX FACTORS;

EID: 84958211766     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147533     Document Type: Article

References (21)

1. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117(5):1219-1222. PMID: 17476353
2. Tanudjaja T, Chantelau E. Recurrent Diabetic foot lesions-A study of disease activity in high risk patients. Proceedings of the Second International Symposium on the Diabetic Foot: 10-12 May 1995; Noordwijkerhout. Edited by Nicolaas Christian Schaper and K Bakker: Wiley; 1995.
3. Morbach S, Icks A, Rümenapf G, Armstrong DG. Comment on: Bernstein. Reducing foot wounds in diabetes. Diabetes Care. 2013;36:e48, Diabetes Care 36(4), e62.
4. Armstrong DG, Mills JL. Toward a change in syntax in diabetic foot care: prevention equals remission. J Am Podiatr Med Assoc. 2013;103(2):161-162. PMID: 23536510
5. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990;13(5):513-521. PMID: 2351029
6. Icks A, Haastert B, Trautner C, Giani G, Glaeske G, Hoffmann F. Incidence of lower-limb amputations in the diabetic compared to the non-diabetic population. Finding from nationwide insurance data, Germany, 2005-2007. Exp Clin Endocrinol Diabetes. 2009;117:500-504. doi: 10.1055/s-0029-1225333 PMID: 19629934
7. Hoffmann F, Claessen H, Morbach S, Waldeyer R, Glaeske G, Icks A. Impact of diabetes on costs before and after major lower amputations in Germany. J Diab Compl. 2013;27(5):467-472.
8. Icks A, Scheer M, Morbach S, Genz J, Haastert B, Giani G, et al. Time-dependent impact of diabetes on mortality in patients after major lower extremity amputation: Survival in a population-based 5-year cohort in Germany. Diabetes Care. 2011;34(6):1350-1306. doi: 10.2337/dc10-2341 PMID: 21540432
9. Brownrigg JR., Griffin M, Hughes CO, Jones KG, Patel N, Thompson MM, et al. Influence of foot ulceration on cause-specific mortality in patients with diabetes mellitus. J Vasc Surg. 2014; doi: 10.1016/j.jvs. 2014.04.052
10. Armstrong DG, Wrobel J, Robbins JM. Guest Editorial: are diabetes-related wounds and amputations worse than cancer? Int Wound J. 2007;4(4):286-287. PMID: 18154621
11. Robbins JM, Strauss G, Aron D, Long J, Kuba J, Kaplan Y. Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration? J Am Podiatr Med Assoc. 2008;98(6):489-493. PMID: 19017860
12. Pound N, Chipchase S, Treece K, Game F, Jeffcoate W. Ulcer-free survival following management of foot ulcers in diabetes. Diabet Med. 2005;22(10):1306-1309. PMID: 16176187
13. Morbach S, Furchert H, Gröblinghoff U, Hoffmeier H, Kersten K, Klauke G-T, et al. Long-term prognosis of diabetic foot patients and their limbs: Amputation and death over a decade. Diabetes Care. 2012;25(10):2021-2027.
14. Kalbfleisch JD, Prentice RL. The statistical Analysis of Failure Time Data. New York: Wiley; 2002.
15. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman and Hall; 1996.
16. Welton NJ, Ades AE. Estimation of Markov Chain Transition Probabilities and Rates from Fully and Partially Observed Data: Uncertainty Propagation, Evidence Synthesis, and Model Calibration. Med Decis Making. 2005;25:633-45. PMID: 16282214
17. Begun A, Icks A, Waldeyer R, Landwehr S, Koch M. Identification of a Multistate Continuous-Time Nonhomogeneous Markov Chain Model for Patients with Decreased Renal Function. Med Dec. Making. 2013;33:298-306.
18. De Wreede L. C., Fiocco M., Putter H. mstate: An R Package for the Analysis of Competing Risks and Multi-State Models. Journal of Statistical Software. 2011;38(7):1-30.
19. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993;233(6):485-491. PMID: 8501419
20. Faglia E, Favales F, Morabito A. New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up. Diabetes Care. 2001;24(1):78-83. PMID: 11194246
21. Izumi Y, Satterfield K, Lee S, Harkless LB, Lavery LA. Mortality of first-time amputees in diabetics: a 10-year observation. Diabetes Res Clinical Pract. 2009;83(1):126-131.